A peer across the Pacific Ocean has purchased the rights to one of the biotech’s pipeline drugs. On Monday, investors clearly saw excellent value in the stock of Ocugen (OCGN 11.68%), a biotech that concentrates on treatments for eye disorders. They traded the company’s shares up by more than 12%, on the back of a […]
Why Ocugen Stock Zoomed 12% Higher Today Read More »
Hecla mines precious metals, but it was the stock itself that was looking like gold as the trading week began. Hecla Mining (HL 12.14%) stock was quite a winner on Monday, but not because of anything the company extracted from the ground. Rather, investors piled into the mining company because of its ascension to a
Why Hecla Mining Stock Zoomed 12% Higher Today Read More »
It’s always encouraging to get what appears to be good news from the FDA. On a very good Friday for the stock market, Biohaven‘s (BHVN 6.33%) performance was exceptional. The clinical-stage biotech’s share price inflated by over 6% that trading session thanks to regulatory news it delivered in the morning. Even the surging S&P 500
Why Biohaven Stock Zoomed More Than 6% Higher Today Read More »
At just 12x this year’s free cash flow, Zoom Communications stock could be an incredible buy. Pandemic communications star Zoom Communications (ZM 10.22%) stock, um (I’m trying not to say “zoomed”), moved ahead quickly Friday morning, rising 8% through 9:50 a.m. ET after beating soundly on its fiscal Q2 2026 earnings report last night. Analysts
Why Zoom Communications Stock Zoomed Today Read More »